International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia

Stopped Poor recruitment, due to a change in the standard of care for this patient population with the use of CAR-T cells

Conditions

• Acute Lymphoblastic Leukemia
• Acute Lymphoblastic Leukemia, Adult
• Acute Lymphoblastic Leukemia, Pediatric
• Acute Lymphoblastic Leukemia, in Relapse
• Acute Lymphoblastic Leukemia Recurrent

Interventions

• DRUG: Selumetinib
• DRUG: Dexamethasone

Sponsor

University of Birmingham

Collaborators

• [object Object]
• [object Object]